Bachem Holding AG
Research Bachem Holding AG (BANB) on Bullrun: market cap CHF 5.80B, P/E 39.0, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBANB
- ExchangeSW
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCHF
- Market capCHF 5.80B
- P/E39.0
- Dividend yield1.2%
- Financial periodFY2025
- RevenueCHF 695.07M
- Revenue growth14.8%
- Net incomeCHF 148.79M
- Free cash flow-CHF 57.82M
- Gross margin28.7%
Valuation Snapshot
latest market cap is CHF 5.80B; P/E is 39.0; dividend yield is 1.2%.
Peer valuation comparison
Latest P/E is 39.02x versus a Healthcare sector median of 24.46x (59.5% above).
Latest dividend yield is 1.17% versus a Healthcare sector median of 2.11% (44.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 695.07M | CHF 148.79M | -CHF 57.82M | 28.7% | 1.98 | CHF 30.99M | n/a | CHF 1.46B |
| FY2024 | CHF 605.26M | CHF 120.25M | -CHF 138.30M | 30.2% | 1.6 | CHF 95.20M | CHF 290.00K | CHF 1.39B |
| FY2023 | CHF 577.32M | CHF 111.86M | -CHF 18.54M | 30.7% | 1.5 | CHF 157.73M | CHF 401.00K | CHF 1.32B |
| FY2022 | CHF 531.74M | CHF 100.68M | -CHF 49.70M | 32.2% | 1.37 | CHF 31.45M | CHF 352.00K | CHF 1.17B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | CHF 5.80B | 39.0 | 1.2% | 0.9 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.9 CHF, yield 1.2%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.85 CHF |
| FY2024 | 0.8 CHF |
| FY2023 | 0.75 CHF |
| FY2022 | 0.7 CHF |
| FY2021 | 0.65 CHF |
About Bachem Holding AG
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bachem Holding AG's market cap?
Bachem Holding AG's market capitalization is CHF 5.80B.
What is Bachem Holding AG's P/E ratio?
Bachem Holding AG's price-to-earnings (P/E) ratio is 39.0.
Does Bachem Holding AG pay a dividend?
Bachem Holding AG has a dividend yield of 1.2%.
What does Bachem Holding AG do?
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services.